CAMBRIDGE, Mass., May 04, 2026 (GLOBE NEWSWIRE)-- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, ...
Win statistics offer a new approach to the analysis of outcomes in clinical trials, allowing the combination of time-to-event and longitudinal measurements and taking into account the clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
